(NYSE:AGL) NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (âKSFâ), announces that KSF has continued its investigation into agilon health, inc. (âagilonâ or the âCompanyâ) (NYSE: AGL). On January 5, 2024, the Company disclosed that it was slashing its 2023 profit forecasts, specifically, lowering its 2023 Medical Margin expectation to â$340 million to $360 million, approximately $110 million
Related Questions
How might the ongoing investigation by Kahn Swick &âŻFoti affect Agilon Healthâs financial outlook and valuation?
What is the expected shortâterm impact on AGLâs stock price and trading volume given the profit forecast cut and legal uncertainty?
How does this legal exposure compare to similar healthâservices peers and could it influence the companyâs competitive positioning?